HomeЛюди и блогиRelated VideosMore From: Daily News

COMPASS Trial Results How Could They Change CAD PAD Treatment - Daily News

0 ratings | 98 views
COMPASS Trial Results How Could They Change CAD PAD Treatment - Daily News. The rivaroxaban plus aspirin combination therapy to treat patients with stable coronary or peripheral artery disease showed such benefits in the COMPASS trial that it should become the standard of care, said John Eikelboom, MBBS, MSc, FRCPC, associate professor at McMaster University.
Html code for embedding videos on your blog
Text Comments (0)

Would you like to comment?

Join YouTube for a free account, or sign in if you are already a member.